Molecular analysis of human papillomavirus in never-smokers with non-small cell lung cancer
- PMID: 25621070
- PMCID: PMC4301494
- DOI: 10.3892/ol.2014.2713
Molecular analysis of human papillomavirus in never-smokers with non-small cell lung cancer
Abstract
The causes of lung cancer in never-smokers remain unclear. The potential contribution of human papillomavirus (HPV) to the carcinogenesis of non-small cell lung cancer (NSCLC) has been reported. In 2008, a prospective registry of never-smokers with NSCLC was established at the Kinki-Chuo Chest Medical Center, Sakai, Osaka, Japan. Never-smokers with NSCLC were consecutively enrolled onto the registry. Of these patients, 114 with large tumor specimens, the majority of which were surgical tissues, were selected. In total, 23 of the most clinically relevant HPV types were assayed using polymerase chain reaction amplification of the viral genome. Following exclusion of samples with suboptimal quality, DNA was extracted from 96 formalin-fixed paraffin-embedded samples. These 96 cases consisted of 82 females (85.4%) and 14 males (14.6%), with a median age of 67 years (range, 29-83). Almost all cases (93.8%) were of the adenocarcinoma histological subtype. Despite confirmation of the quality and amount of DNA, HPV type 6 was detected in only one case (1.1%). Furthermore, no other samples examined were positive for any other HPV types. The results therefore suggest that HPV does not play a major role as the driving oncogenic event in never-smokers with NSCLC.
Keywords: human papillomavirus; lung cancer; never-smokers; prospective registry.
Similar articles
-
Laboratory-developed L1 sequencing and type-specific, real-time polymerase chain reaction for the detection and typing of human papillomaviruses in formalin-fixed, paraffin-embedded tissues.Arch Pathol Lab Med. 2013 Jan;137(1):50-4. doi: 10.5858/arpa.2011-0392-OA. Arch Pathol Lab Med. 2013. PMID: 23276174
-
Human papillomavirus (HPV) and Merkel cell polyomavirus (MCPyV) in non small cell lung cancer.Exp Mol Pathol. 2010 Dec;89(3):222-6. doi: 10.1016/j.yexmp.2010.08.001. Epub 2010 Aug 7. Exp Mol Pathol. 2010. PMID: 20699096
-
Detection of the human papillomavirus in cervical carcinoma: a comparison between non-isotopic in-situ hybridisation and polymerase chain reaction as methods for detection in formalin-fixed, paraffin-embedded tissues.Malays J Pathol. 2008 Jun;30(1):37-42. Malays J Pathol. 2008. PMID: 19108410
-
Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis.Clin Cancer Res. 2003 Jul;9(7):2620-6. Clin Cancer Res. 2003. PMID: 12855639
-
Carcinoma of the lung in Okinawa, Japan: with special reference to squamous cell carcinoma and squamous metaplasia.Pathol Int. 1997 Oct;47(10):659-72. doi: 10.1111/j.1440-1827.1997.tb04439.x. Pathol Int. 1997. PMID: 9361099 Review.
Cited by
-
Overexpression of Human Papillomavirus Type 16 Oncoproteins Enhances Epithelial-Mesenchymal Transition via STAT3 Signaling Pathway in Non-Small Cell Lung Cancer Cells.Oncol Res. 2017 May 24;25(5):843-852. doi: 10.3727/096504016X14813880882288. Epub 2016 Dec 15. Oncol Res. 2017. PMID: 28508744 Free PMC article.
-
Infection with human cytomegalovirus, Epstein-Barr virus, and high-risk types 16 and 18 of human papillomavirus in EGFR-mutated lung adenocarcinoma.Croat Med J. 2023 Apr 30;64(2):84-92. doi: 10.3325/cmj.2023.64.84. Croat Med J. 2023. PMID: 37131310 Free PMC article.
-
HPV and lung cancer: A systematic review and meta-analysis.Cancer Rep (Hoboken). 2021 Aug;4(4):e1350. doi: 10.1002/cnr2.1350. Epub 2021 Feb 23. Cancer Rep (Hoboken). 2021. PMID: 33624444 Free PMC article.
-
HPV and Lung Cancer: A Systematic Review.Cancers (Basel). 2024 Sep 28;16(19):3325. doi: 10.3390/cancers16193325. Cancers (Basel). 2024. PMID: 39409943 Free PMC article. Review.
-
Involvement of TP53 and TP16 expression in human papillomavirus-associated non-small cell lung cancer.Oncol Lett. 2016 Nov;12(5):3330-3336. doi: 10.3892/ol.2016.5087. Epub 2016 Sep 5. Oncol Lett. 2016. PMID: 27900000 Free PMC article.
References
-
- Kawaguchi T, Takada M, Kubo A, et al. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC. J Thorac Oncol. 2010;5:620–630. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources